ACEA Pharma Acquired by Phoenix Asia Holdings | Healthcare M&A Deal

Phoenix Asia Holdings has acquired ACEA Pharma, a pharmacy business in California, for $1,000,000,000. Phoenix Asia Holdings acquisitions focus on building a go-forward platform by renaming the acquired entity to ACEA Pharma, Inc. ACEA Pharma operates in the healthcare sector with a pharmacy portfolio tied to non-opioid pain management products and related therapeutic commercialization. The healthcare M&A transaction is structured as a platform acquisition by a public company, with ACEA Thera delivering newly issued Phoenix shares at $10.00 per share and expecting closing by the end of Q2 2026, subject to regulatory and Nasdaq approvals.